Back to search
FDAFDA · Food and drugs·Recall number D-0539-2026

Busulfan Injection, 60 mg per 10 mL (6 mg per mL), 8x10 mL Single-Dose Vials, Rx only, Mfd. for Sagent Pharmaceuticals, Schaumburg, IL 60195, Made in Canada, NDC 25021-241-10.

Published May 27, 2026 · Recall initiated: May 4, 2026

Summary

FDA records drug Class III recall D-0539-2026, published May 27, 2026 and initiated May 4, 2026. Recalling firm: Sagent Pharmaceuticals; Status: Ongoing; Reported quantity: Lot 656412: 6,200 vials. Lot 659646: 3,328 vials.; Lot: Lot #: 656412, Exp. Date 08/31/2026; 659646, Exp. Date 03/31/2027. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if BUSULFAN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
BUSULFAN
Manufacturer
Sagent Pharmaceuticals
Distributor
Nationwide within the United States
Lot
Lot #: 656412, Exp. Date 08/31/2026; 659646, Exp. Date 03/31/2027.
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Busulfan Injection, 60 mg per 10 mL (6 mg per mL), 8x10 mL Single-Dose Vials, Rx only, Mfd. for Sagent Pharmaceuticals, Schaumburg, IL 60195, Made in Canada, NDC 25021-241-10. recalled?

Yes. FDA published recall D-0539-2026 on May 27, 2026. Reported hazard: Failed Impurities/Degradation Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: BUSULFAN.